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doi:10.1016/j.tcmj.2012.01.001Pneumocystis jirovecii pneumonia (PCP) is a potentially life-
threatening infection encountered in immunocompromised indi-
viduals [1]. The radiographic appearance of a cavity in Pneumocystis
jirovecii pneumonia is unusual [2]. Delayed diagnosis and treatment
could result in a poor outcome [1]. We report a patient with
systemic lupus erythematosus (SLE) who developed a cavitating
pneumonia in the presence of PCP.
A 57-year-old woman with SLE, hypertension and chronic renal
failure had chest pain and dyspnea for 3 days. Her medications
for SLE included oral azathioprine 50 mg four times per day,
oral methylprednisolone 12 mg twice daily and oral hydroxy-
chloroquine 200 mg twice daily. In addition, she underwent two
courses of pulse therapy with methylprednisolone for active
lupus nephritis in the past 3 months. Her initial chest radiograph
showed dense right upper lobe consolidation (Fig. 1A). The
initial blood examination revealed white blood cells 3600/mL (N
bands 7%, N segments 88%); creatinine 6.18 mg/dL; and C-reactive
protein 35.32 mg/dL. Empirical intravenous cefepime 1000 mg
every 12 hours was started, but right upper lobe cavitation ensued.
The patient developed respiratory distress despite broad-spectrum
antimicrobial agents. Chest computed tomography on Day 24
demonstrated a large right upper lobe cavity and diffuse mosaic
ground-glass opacities (Fig. 1B). A video-assisted thoracoscopic
wedge biopsy revealed consolidation of the lung. The alveolarMedicine, Buddhist Tzu Chi
, New Taipei City, Taiwan.
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ddhist Compassion Relief Tzu Chispaces were ﬁlled with frothy alveolar exudates (Fig. 1C). Periodic
acid-Schiff and Grocott’s methenamine silver stains revealed
Pneumocystis jirovecii in the alveolar spaces (Fig. 1D). Intravenous
sulfamethoxzole-trimethoprim (240 mg trimethoprim every 6
hours) and intravenous methylprednisolone 40 mg every
12 hours were administered. The patient died on the 40th day of
hospitalization.
The incidence of PCP among patients with acquired immunode-
ﬁciency syndrome (AIDS) has declined since the introduction of
highly active antiretroviral therapy. However, PCP has increased
markedly among patientswith connective tissue diseases because of
intense immunosuppressive treatment. The outcome has improved
for AIDS patients with PCP because of a high index of suspicion and
timely application of appropriate antibiotics and corticosteroids [3].
However, pulmonary manifestations in patients with connective
tissue diseases are complex and the mortality among non-AIDS
patients with PCP remains high, partly because of delay in diag-
nosis. Risk factors for patients with SLE to develop PCP are high
disease activity, renal involvement, high daily corticosteroid dosage
and lymphocytopenia [4]. The typical radiographic features of PCP in
non-AIDS patients are diffuse, bilateral, interstitial inﬁltrates [5]. The
initial radiographic appearance of a cavity in PCP is unusual. Lung
cavitation manifests rarely in only 3.8% of patients with PCP and has
been reported to simulate tuberculosis [2]. Milligan et al. described
eight patients with PCP who were initially diagnosed with pulmo-
nary tuberculosis and were started on antituberculosis treatment
[6]. The differential diagnosis for pulmonary cavitary mass lesions
with associated consolidation includes pulmonary tuberculosis,
bacterial lung abscess, invasive fungal infection and Wegener’s
granulomatosis [7]. For immunocompromised hosts with nodularFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) Initial chest radiograph shows dense right upper lobe consolidation. (B) Chest computed tomography shows a large right upper lobe cavity with diffuse mosaic ground-
glass opacities. (C) Hemotoxylin and eosin stain reveals consolidation of the lung. The alveolar spaces are ﬁlled with frothy alveolar exudates (100). (D) Periodic acid-Schiff and
Grocott’s methenamine silver stains reveal Pneumocystis jirovecii in the alveolar spaces (400).
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involvement from Kaposi’s sarcoma should be considered [8]. With
the evolving trend of immunosuppressive treatment, a high index
of suspicion is advised for timely diagnosis of this potentially
treatable complication among patients with connective tissue
diseases. An aggressive diagnostic approach including invasive
procedures is required in an immunocompromised host with
unexplained pulmonary inﬁltrates. Early appropriate antibiotic
administration enhances the chances of recovery in these patients.References
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